Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
出版年份 2019 全文链接
标题
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-09
DOI
10.1038/s41419-018-1274-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes
- (2017) Prasad L. Gawade et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression
- (2016) Vince Kornél Grolmusz et al. BMC GENOMICS
- TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data
- (2016) Liacine Bouaoun et al. HUMAN MUTATION
- A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
- (2016) Brian Leyland-Jones et al. JOURNAL OF CLINICAL ONCOLOGY
- Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis
- (2016) Michael I. Carr et al. Cell Reports
- Experimental and investigational therapies for chemotherapy-induced anemia
- (2015) Ugo Testa et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regulation of MDM2 Stability After DNA Damage
- (2015) Jiaqi Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- IL-17 induces radiation resistance of B lymphoma cells by suppressing p53 expression and thereby inhibiting irradiation-triggered apoptosis
- (2014) Qingshan Li et al. Cellular & Molecular Immunology
- Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem-like Cells to Protect Them from Chemotherapy
- (2013) M. Todaro et al. CANCER RESEARCH
- Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells
- (2012) Chi Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer
- (2012) M Aapro et al. BRITISH JOURNAL OF CANCER
- p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
- (2012) James G. Jackson et al. CANCER CELL
- Erythropoietin: The swinging pendulum
- (2012) Howard S. Oster et al. LEUKEMIA RESEARCH
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- Delving deeper: MCL-1's contributions to normal and cancer biology
- (2012) Rhonda M. Perciavalle et al. TRENDS IN CELL BIOLOGY
- Erythropoietin, erythropoiesis and beyond
- (2011) S. Chateauvieux et al. BIOCHEMICAL PHARMACOLOGY
- Analysis of microRNA expression profiles during the cell cycle in synchronized HeLa cells
- (2011) Jue-Yu Zhou et al. BMB Reports
- The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation
- (2011) Qian Cheng et al. CELL CYCLE
- Deep Sequencing Reveals Novel MicroRNAs and Regulation of MicroRNA Expression during Cell Senescence
- (2011) Joseph M. Dhahbi et al. PLoS One
- Erythropoietin: back to basics
- (2010) W. Jelkmann BLOOD
- Senescent cells as a source of inflammatory factors for tumor progression
- (2010) Albert R. Davalos et al. CANCER AND METASTASIS REVIEWS
- Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
- (2010) Ke Liang et al. CANCER CELL
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- Erythropoietin: not just about erythropoiesis
- (2010) Pietro Ghezzi et al. LANCET
- Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis
- (2009) M. Tonelli et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Modes of p53 Regulation
- (2009) Jan-Philipp Kruse et al. CELL
- The miR-34 family in cancer and apoptosis
- (2009) H Hermeking CELL DEATH AND DIFFERENTIATION
- Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
- (2009) Julia Bohlius et al. LANCET
- Erythropoietin protects PC12 cells from β-amyloid25–35-induced apoptosis via PI3K/Akt signaling pathway
- (2009) Rong Ma et al. NEUROPHARMACOLOGY
- Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells
- (2008) Randolph M. Abutin et al. EXPERIMENTAL HEMATOLOGY
- Mechanisms of regulatory diversity within the p53 transcriptional network
- (2008) J M Espinosa ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started